Allogene Therapeutics has reported phase 1 data on its solid tumor CAR-T, linking the off-the-shelf cell therapy candidate to ...

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma. The Food and Drug Administration (FDA) granted ...

Preclinical studies have suggested that CAR T cells that target CD123 (CART-123) could be effective. The current study evaluates the safety and efficacy of CART-123 in adult patients with relapsed ...

EU regulators are requiring makers of CART T cell therapies to update their product labeling to include information that recipients may be at increased risk for developing secondary T cell cancers.

What they found was a T-cell inside people's blood. This is an immune cell that can scan the body to assess whether there is a threat that needs to be eliminated. The difference is this one could ...

These cells deal with microbes and repair tissue damage. Two main sub-types of immune cells are T cells and macrophages. T cells are designed to recognise the molecular signatures of particular ...

ICER has given tabelecleucel a rating of A, indicating the T cell therapy for Epstein-Barr virus related post-transplant ...

Learn more about anemia. Acute chest syndrome (ACS) is a life threatening possible complication of SCD. Sickled cells can stick together and block blood and oxygen delivery to the lungs.

The CD4 count is a test that measures how many CD4 cells you have ... with few complications. But those patients are at risk of becoming very ill if they don’t start HIV treatment.